Yaping Shou, Venture Partner at Lilly Asia Ventures, Discusses U.S.-China Biotech Trends-BIO CEO2023

Yaping Shou, MD, Ph.D., Venture Partner at Lilly Asia Ventures and CEO of Wells Therapeutics, discusses U.S.-China biotech trends – 2023 BIO CEO and Investor Conference

source